Catalent, based in Philadelphia, PA, is a leading provider of integrated development solutions for pharmaceutical, biotech, and consumer health companies. With a focus on oral dose development, bioavailability enhancement, and formulation services, Catalent offers a wide range of solutions to help innovators deliver superior products that improve people's lives.
As the #1 partner in contract development and manufacturing organization (CDMO) services, Catalent is committed to long-term progress and corporate responsibility. With a diverse portfolio of drug delivery technologies and manufacturing platforms, Catalent aims to simplify and de-risk programs for emerging biotech companies seeking clinical supply, consumer health, and cell and gene therapy solutions.
Generated from the website